JPMorgan Just Raised Its View on Chemours (CC)—What Changed?

With an upside potential of 25.65% according to analysts, The Chemours Company (NYSE:CC) is among the 10 Most Promising Hydrogen and Fuel Cell Stocks According to Analysts.

On May 21, JPMorgan analyst Jeffrey Zekauskas raised the firm’s price target for The Chemours Company (NYSE:CC) to $22 from $17 while maintaining a Neutral rating on the shares. The upward revision reflects an improved outlook for the company’s operating performance and suggests that JPMorgan sees greater value in the stock relative to its previous assessment.

On May 13, Alembic Global increased its price target on The Chemours Company (NYSE:CC) to $30 from $24 and reiterated an Overweight rating on the shares. The higher target price and continued positive rating indicate confidence in the company’s growth prospects and its ability to benefit from favorable trends across its core end markets.

Founded in 2015 and headquartered in Wilmington, Delaware, The Chemours Company (NYSE:CC) manufactures critical titanium technologies, fluoroproducts, and chemical solutions for major industries. It produces Nafion membranes, the foundational ion-exchange material utilized in hydrogen fuel cells and electrolyzers for clean energy and mobility applications.

READ NEXT: 10 Most Overvalued Quantum Computing Stocks According to Short Sellers and 10 Stocks That Could Double Over the Next 2 Years.

Disclosure: None.  Follow Insider Monkey on Google News.